• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Erlotinib
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    partial basket chart

    Tyrosine Kinase Inhibitor. Erlotinib 100 mg, 150 mg.
    TABS: 30 x 100 mg, 150 mg. Non-small
    cell lung cancer: 150 mg 1 x dly
    without food. Pancreat. cancer: 100 mg
    dly without food in comb. with
    First-line tmt. locally advanced/metastat.
    non-small cell lung cancer (NSCLC) with
    EGFR activat. mutats. Tmt. locally.
    advanced/metastat. NSCLC aft. fail. of at
    least one prior chemother. reg. Monother.
    for maint. tmt. pts with locally advanc./
    metastat. non-small cell lung cancer
    whose disease not progress. aft. 4 cycles of
    platinum-based first-line chemother. In
    comb. with gemcitabine for first-line tmt.
    with locally advanced, unresect./
    metastat. pancreat. cancer.
    C/I: Hypersens. to erlotinib or excips.